Keywords: ایمنی زایی; Immunogenicity; Anti-drug antibody; ADA; Drug interference; Drug tolerance; Target interference; Immunoassay; Ligand binding assays;
مقالات ISI ایمنی زایی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ایمنی زایی; Enterovirus 71; Virus-like particles; VLP; Vaccine; Immunogenicity;
Keywords: ایمنی زایی; ClinicalTrials.gov: NCT01134263; Flavivirus; Dengue; Vaccine; Immunogenicity;
Keywords: ایمنی زایی; Human butyrylcholinesterase; Pharmacokinetics; Immunogenicity; Aerosol delivery; Monkey model; Animal Rule; BChE; butyrylcholinesterase; Ma; macaque; aer; aerosol;
Keywords: ایمنی زایی; Booster; Vaccine; Immunogenicity; Safety; Tdpa; acellular pertussis vaccine; Antibody persistence; Aluminium; AE; adverse event; ATP; according to protocol; BR; booster response; CI; confidence interval; DT; diphtheria toxoid; dTpa; reduced antigen conten
Keywords: ایمنی زایی; Pregnancy; Influenza; Vaccine; Vaccine safety; Immunogenicity; Transplacental transfer
Keywords: ایمنی زایی; TPP; therapeutic protein product; ADA; anti-drug antibody; mAb; monoclonal antibody; RA; rheumatoid arthritis; MS; multiple sclerosis; IBD; inflammatory bowel disease; NAb; neutralizing ADA; non-NAb; non-neutralizing ADA; PK; pharmacokinetics; PRCA; pure
Keywords: ایمنی زایی; Dengue; Dengue vaccines; Virus-like particles; Immunogenicity;
Keywords: ایمنی زایی; Dengue; Envelope; Subunit vaccine; Immunogenicity; Efficacy
Keywords: ایمنی زایی; adipose tissue-derived stromal cells (ASCs); alginate; immunogenicity; immunosuppression; injectable hydrogel; licensing;
Keywords: ایمنی زایی; Anti-drug antibody; Immunoassays; Immunogenicity; Screening cut point; Software
Keywords: ایمنی زایی; Particulate matter; Particle; Protein; Biopharmaceutical; In-line filtration; Immunogenicity;
Keywords: ایمنی زایی; ADA; Anti-drug antibody(ies); ADCC; Antibody-dependent cellular cytotoxicity; AE; Adverse event; CBA; Cell-based assay; CDC; Complement dependent cytotoxicity; CLB; Competitive ligand binding; EIP; European Immunogenicity Platform; EIP-AWG; European Immun
Keywords: ایمنی زایی; Coadministration; Concomitant; HPV vaccination; Immunogenicity; Safety;
Keywords: ایمنی زایی; Children; Infant; Influenza; Influenza vaccine; Immunogenicity; Safety;
Keywords: ایمنی زایی; Influenza; Vaccines; Neuraminidase; Stability; Immunogenicity
Keywords: ایمنی زایی; TNF inhibitor; Immunogenicity; Antidrug antibody; Rheumatoid arthritis; Ankylosing spondylitis;
Keywords: ایمنی زایی; NCT01559597; Controlled temperature chain; Cold chain; Tetanus toxoid; Immunogenicity; Maternal and neonatal tetanus elimination;
Keywords: ایمنی زایی; adverse events; immunogenicity; low birth weight; pneumococcal-CRM197 conjugate vaccine; prematurity; Streptococcus pneumoniae
Keywords: ایمنی زایی; Shigella; Live bivalent vaccine candidates; Rhesus monkeys; Colonization; Immunogenicity
Keywords: ایمنی زایی; Cancer stem cells; Glioblastoma; Colorectal carcinoma; Immunogenicity; Immunosuppression;
Keywords: ایمنی زایی; Rotavirus vaccines; India; BRV-TV; Safety; Immunogenicity;
Keywords: ایمنی زایی; Dengue vaccine; Pseudoinfectious virus; Replicon; Packaging cell; Immunogenicity;
Keywords: ایمنی زایی; Dengue vaccine; CYD-TDV; Meta-analysis; Safety; Efficacy; Immunogenicity;
Keywords: ایمنی زایی; Yellow fever vaccine; Immunogenicity; Vaccination policy;
Keywords: ایمنی زایی; Zaire Ebola virus; Glycoprotein; Fragment; Immunogenicity; Neutralizing antibody; Polyvalent vaccine;
Keywords: ایمنی زایی; Immunogenicity; Cell-based; Neutralizing antibody; Matrix interference; PDGF; MEDI-575;
Keywords: ایمنی زایی; Oral polio vaccine, OPV; Inactivated polio vaccine, IPV; Model; Polio eradication; Poliovirus vaccine efficacy; Immunogenicity
Keywords: ایمنی زایی; Coiled-coil peptides; Enantiomers; Immunogenicity; HPMA copolymer; Fab' fragment; Drug-free macromolecular therapeutics;
Keywords: ایمنی زایی; protein; aggregates; immunogenicity; microparticles; adsorption; adjuvant effect; anti-drug antibody (ADA); monoclonal antibody (mAb); ELISA assay; infrared spectroscopy; mAb monoclonal antibody; ADA anti-drug antibody; ELIS Aenzyme-linked immunosorbent a
Keywords: ایمنی زایی; Antidrug antibodies; Biologic agents; Drug allergy; Hypersensitivity reactions; Immunogenicity;
Keywords: ایمنی زایی; Live Oka varicella vaccine; Diabetes mellitus; Cell-mediated immunity (CMI); Immunogenicity; Safety; Herpes zoster;
Keywords: ایمنی زایی; Varicella vaccine; Immunogenicity; Safety; Efficacy; Routine vaccination program; Two-dose schedule;
Keywords: ایمنی زایی; Influenza vaccine; Quadrivalent; Immunogenicity; Safety; Adults; United States;
Keywords: ایمنی زایی; Influenza; Vaccine; Quadrivalent; Trivalent; Immunogenicity; Safety;
Keywords: ایمنی زایی; Helicobacter pylori; Neutrophil-activating protein; Chimeric antigens; Immunogenicity; Measles virus vaccine;
Keywords: ایمنی زایی; Localization; Cell wall; Physiopathology; Immunogenicity; Diagnosis; Mycobacterium; TAG; triacylglycerol; FM; foamy macrophage; LB; lipid body; ILI; intracellular lipidic inclusion; TB; tuberculosis; PPD; protein purified derivative;
Keywords: ایمنی زایی; CYD-TDV; recombinant live-attenuated tetravalent dengue vaccine; PRNT50; plaque reduction neutralization test; RT-PCR; reverse transcriptase-polymerase chain reaction; TCID50; log10tissue culture infectious dose 50%; Clinical trial; Dengue; Formulation; I
Keywords: ایمنی زایی; Liposome; Thiomer; S-protected thiomer; Permeation enhancement; Efflux pump inhibition; Immunogenicity;
Keywords: ایمنی زایی; bioequivalence; pharmacokinetics/pharmacodynamics; protein formulation; glycoprotein; FII; FVII; FX; immunogenicity; transgenics;
Keywords: ایمنی زایی; Pneumococcal conjugate vaccine; Safety; Immunogenicity; Meta-analysis;
Keywords: ایمنی زایی; Confirmatory method; Confirmation method; Immunogenicity; Antidrug antibody; Anti-therapeutic antibody; Cut point;
Keywords: ایمنی زایی; Opsonophagocytic killing assay; Pneumococcal vaccine; Immunogenicity; Streptococcus pneumoniae;
Keywords: ایمنی زایی; Adalimumab; Immunogenicity; Anti-drug antibodies; Human monoclonal antibodies; Anti-idiotype Antibodies
Keywords: ایمنی زایی; conjugated pneumococcal vaccine; cost-effectiveness; efficacy; immunogenicity; interchangeability; safety
A comparison among β-caseins purified from milk of different species: Self-assembling behaviour and immunogenicity potential
Keywords: ایمنی زایی; Beta-casein; Self-assembly; Immunogenicity; Human; Donkey; Goat; Sheep; Dynamic light scattering;
Evaluation of an outer membrane protein as a vaccine against Edwardsiella anguillarum in Japanese eels (Anguilla japonica)
Keywords: ایمنی زایی; Edwardsiella anguillarum; OmpA; Vaccine; Expression and purification; Immunogenicity; Anguilla japonica;
Long-term follow-up of HIV-1-infected adults who received the F4/AS01B HIV-1 vaccine candidate in two randomised controlled trials
Keywords: ایمنی زایی; HIV type 1 vaccine; Recombinant fusion protein; Persistence; Efficacy; Immunogenicity; Safety; AE; adverse event; ART; antiretroviral therapy; ATP; according-to-protocol; CI; confidence interval; GMC; geometric mean concentration; HIV-1; human immunodefic
A comparative study between outbred and inbred rat strains for the use in in vivo IPV potency testing
Keywords: ایمنی زایی; Inactivated poliovirus vaccine; Animal model; Sabin; Salk; Neutralizing antibodies; Immunogenicity; ELISA; enzyme-linked immunosorbent assay; EP; European Pharmacopoeia; GMT; geometric mean antibody titer; IPV; inactivated poliomyelitis vaccines; OPV; ora
Evaluation of cellular immunogenicity of recombinant cytochrome p450 cyp141 protein of Mycobacterium tuberculosis in human and mouse model
Keywords: ایمنی زایی; Immunogenicity; Recombinant cytochrome P450 CYP141; DDA adjuvant; IFN-γ & IL4; Mycobacterium tuberculosis;